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CD11bF monocytic/macrophagic cells that infiltrate
human skin after in vivo ultraviolet exposure potently
produce interleukin-10. We hypothesized that binding
of monocyte b1 integrins to ultraviolet-induced extra-
cellular matrix ligands, such as fibronectin, after entry
of blood monocytes into the dermis, is involved in the
modulation of immunoregulatory monocytic cyto-
kines. Immunostaining of human skin and reverse
transcriptase–polymerase chain reaction studies
revealed that the embryonic isoform of cellular
fibronectin, in which the extra domain A (EDA)
segment is spliced in (EDAF cellular fibronectin), and
confers enhanced binding to b1 integrins, is newly
induced and is associated with infiltrating CD11bF
cells post in vivo ultraviolet exposure. We then tested
the effect of fibronectin on resting purified peripheral
monocytes in vitro. We found that monocyte interleu-
kin-10, but not interleukin-12, was significantly
induced in a concentration-dependent manner by
Ultraviolet (UV) induced immunosuppression is awell recognized phenomenon with relevance toskin cancer tumor immunity, response to infectiousdisease, and therapy of immunologically mediatedskin diseases. The modulation by UV of immuno-
regulatory cytokines is one of the critical events relevant to this
immunosuppression, with interleukin (IL)-10 upregulation and
IL-12 downregulation being critical for UV-induced immuno-
suppression of delayed-type hypersensitivity and contact sensitivity
(Schwarz et al, 1994, 1996; Shimizu and Streilein, 1994; Ullrich,
1994; Riemann et al, 1996). We have previously shown that
CD11b1 monocytic/macrophagic cells, which infiltrate into the
dermis (Kang et al, 1998), and epidermis (Kang et al, 1994) after
UV exposure of the skin potently produce IL-10, a well known
immunosuppressive cytokine. The mechanism of induction of IL-
10 production in UV-irradiated skin, however, is not fully explored.
Tissue macrophages derived from circulating monocytes play an
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in vitro binding to cellular fibronectin (n J 6), but not
plasma fibronectin. Tumor necrosis factor-a was also
induced in a concentration-dependent manner, but to
a lesser extent. Monoclonal antibodies to b1 integrins
b-subunit (CD29) also strongly induced tumor necrosis
factor-a and interleukin-10 production, but not
interleukin-12. Neutralization of tumor necrosis fac-
tor-a reduced by 54% the interleukin-10 production
that was induced by monocytes binding to cellular
fibronectin, indicating that interleukin-10 induction is
at least in part dependent upon concomitant autocrine
tumor necrosis factor-a release. In conclusion, ultravi-
olet skin injury results in increased production and
deposition of EDAF cellular fibronectin in the papillary
dermis, which may be one of the key signals capable
of inducing interleukin-10 but not interleukin-12 in
monocytes that infiltrate micromilieu of human skin
after ultraviolet exposure. Key words: adhesion molecules/
cytokines/monocytes/macrophages. J Invest Dermatol 113:
49–55, 1999
important part in host defense involving innate and specific
immunity and tissue repair. Their functions are regulated in large
part through receptors for soluble and insoluble signals (Celada and
Nathan, 1994; Gordon, 1995). β1 and β2 integrins are found on
monocytes and macrophages (Wright et al, 1984; Wright and
Meyer, 1985; Brown et al, 1989; Kohn and Klingemann, 1991;
Owen et al, 1992; Ross and Vetvicka, 1993; Takizawa et al, 1995),
and serve to facilitate adhesion, activation, or differentiation in
response to both cellular and extracellular matrix. In skin, fibronec-
tin (Fn) is a component of the extracellular matrix which is an
important ligand for β1 integrins on monocytes entering the skin.
Cellular Fn (cFn) is thought to be synthesized and secreted locally
in the dermis by fibroblasts, endothelial cells and monocytes as
well as by keratinocytes in the epidermis. Liver cells also synthesize
Fn and secrete it into the plasma and are responsible for the
majority of plasma Fn (pFn), which could also be present in skin
(Clark, 1983). Multiple Fn isoforms are generated from a single
pre-mRNA by alternative splicing at three distinct regions: EDA,
EDB (which are present in cFn, but not in pFn), and IIICS (which
is present in cFn and pFn) (Oyama et al, 1993; Tavian et al, 1994).
With the discovery of EDA, it has become clear that its inclusion
is distinctive of cFn. Although in vivo, EDA1 Fn is poorly
represented in the extracellular matrix of adult normal tissue, it
increases in specific pathologic circumstances such as wound healing
(Ffrench-Constant et al, 1989; Brown et al, 1993), epithelial fibrosis
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(Barnes et al, 1994), and vascular proliferation (Glukhova et al,
1989). It has been speculated that this change in the splicing pattern
provides an extracellular matrix that facilitates wound repair, perhaps
by promoting cell migration.
In normal skin, Fn is mainly deposited along the dermal–
epidermal junction, the walls of blood vessels immediately under-
lying the endothelium and as amorphous granules, fibrils, or patches
in dermis as well (Clark, 1983). Fn is increased at sites of
inflammation in the skin, such as in psoriasis and lichen planus
(Clark, 1983), and it has been documented that UVA and UVB
can induce Fn biosynthesis in hairless mice studied by indirect
immunofluorescence and by weighing extracted Fn from irradiated
mouse skin (Schwartz, 1988; Boyer et al, 1992). It is unknown,
however, whether UV exposure of normal human skin can alter
Fn expression, and which type of Fn is deposited. We hypothesized
the alteration of Fn after UV injury to skin may be a regulatory
factor for monocytes entering into UV-exposed skin. Because Fn
fragments could also be chemotactic for peripheral blood monocytes
(Norris et al, 1982), and because cytokines such as IL-1β can be
rapidly induced by monocyte adherence to extracellular matrix
components or ligation of β1 integrin with antibodies (Yurochko
et al, 1992; Lin et al, 1995), we asked whether UV induces Fn
expression or alteration in its splice variants in human skin. If so,
could the increased Fn component be involved in regulating the
unique cytokine status of monocytes that enter UV-exposed skin
from the blood compartment? We report here that Fn, specifically
the EDA1 splice variant of cFn, are induced in human dermis after
UV. Confirming findings of others using β1 integrin ligands, Fn
induced tumor necrosis factor (TNF)-α and IL-1β production in
monocytes. We found, however, that cFn and β1 integrin ligation
is also a potent inducer of monocyte IL-10, but not IL-12. These
findings implicate UV induction of EDA1 Fn and β1 integrin-
ligand binding as one of the mechanisms of generating the IL-
10high monocytic/macrophagic cell phenotype in the micromilieu
of human skin after UV exposure.
MATERIALS AND METHODS
Subjects Healthy adult volunteers participated in the study after Institu-
tional Review Board approval of the protocol and informed consent.
Keratomes or punch biopsies were performed on the buttocks or hips of
volunteers at different time points after four minimal erythemal doses of
UV irradiation from a bank of six FS40 bulbs, and nonirradiated sites were
used as controls.
Immunohistofluorescence staining The samples were frozen on dry
ice and stored at –80°C. After embedding in OCT Embedding Medium
(Miles; Elkhart, IN), 6 µm sections were cut and thaw mounted on Probe-
On slides (Fisher; Fair Lawn, NJ), fixed with acetone, air dried, and stored
at –80°C. The slides were thawed, hydrated in phosphate-buffered saline
(Amresco, Solon, OH), blocked with 10% goat serum (Accurate Chemical
& Scientific Corporation, Westbury, NY), and treated with primary mouse
monoclonal antibody (MoAb) specific to the extra domain contained in
cFn (EDA sequence) and thus recognizing only cFn (Clone, DH1, IgG1;
ICN Biomedicals, Costa Mesa, CA). For double staining, OKM1 (IgG2b,
anti-CD11b, ATCC No.CRL 8026 cell line; American Type Culture
Collection, Rockville, MD) was used as the other primary antibody.
Isotype controls; IgG1 (Sigma, St. Louis, MO) and IgG2b (Sigma) were
diluted to 1 µg per ml in 10% goat serum phosphate-buffered saline, then
followed by secondary antibodies: fluorescein isothiocyanate-conjugated
goat anti-mouse IgG1 (Boehringer Mannheim, Indianapolis, IN), and
biotinylated goat anti-mouse IgG2b (Caltag, San Francisco, CA), followed
by Rhodamine Red-X conjugated avidin (Molecular Probes, Eugene,
OR). Coverslips were mounted on glass slides with Vectashield Mounting
Medium (Vector, Burlingame, CA). Slides were viewed and photographed
by fluorescence microscopy (Axiophot; Carl Zeiss, Thornwood, NY),
using a triple filter which allowed visualization of multiple fluorescent
markers simultaneously.
Reverse transcriptase–polymerase chain reaction (reverse tran-
scriptase–PCR) Keratomes of skin were incubated in Dispase (50 units
per ml) (Collaborative Biochem, Bedford, MA) at 4°C overnight. Dermis
was separated from epidermis, snap frozen and pulverized with liquid
nitrogen, and subjected to RNA extraction by Qiagen RNA/DNA
Maxi kit (QIAGEN, Chatworth, CA) and the RNA was quantitated by
spectrophotometric measurement. cDNA was synthesized from 500 to
1000 ng (from tissue) of total RNA, and PCR was performed as previously
described (Kang et al, 1994), with some modifications. The cDNA mixture
was mixed with a 60 µl PCR reaction mixture which contained human
Fn EDA primers (primer 1: nucleotides 4775–4798 of the sense strand,
59-GGAGAGAGTCAGCCTCTGGTTCAG-39; primer 2: nucleotides
5149–5125 of the anti-sense strand, 59-TGTCCACTGGGCGCTCAGG-
CTTGTG-39, EDA1 bp 374) (Tavian et al, 1994). Parallel samples were
primed and amplified for β-actin. 30 cycles were conducted in QuarterBath
Immersion Thermal Cycler (INOTECH, Lansing, MI) with denaturation
at 94°C for 1 min, annealing at 55°C (60°C for β-actin) for 1 min and
extension at 72°C for 2 min. PCR products were analyzed by electro-
phoresis on a 1.5% agarose gel with ethidium bromide. The density
of PCR products was quantitated by Optimas 6.1 software (Optimas
Corporation, Bothell, WA). The densitometric values for EDA1 cFn were
normalized to that of β-actin for relative quantitation.
Isolation of monocytes Buffy coat was obtained from peripheral blood
of normal volunteers after Histopaque-1077 (Sigma) centrifugation. After
three washes with Hank’s balanced salt solution plus 1% fetal bovine
serum (FBS, Hyclone Laboratories, Logan, UT), mononuclear cells were
resuspended in RPMI medium 1640 (Gibco BRL, Grand Island, NY)
supplemented with 10% FBS, 1% penicillin/streptomycin (Gibco BRL),
and L-glutamine (Irvine Scientific, Santa Ana, CA). The cells were plated
in 100 mm tissue culture Petri dishes at a concentration of 35–45 3 106
in 5 ml 10% FBS-RPMI and incubated at 5% CO2, 95% humidity, 37°C
for 1 h. After aspirating off nonadherent cells, adherent cells were scraped
off and washed with 1% FBS–Hank’s balanced salt solution. For negative
selection of human monocytes, blocking MoAb (FcγR2, CD32) and MoAb
Cocktail (CD2, CD3, CD19, and CD56) were used, followed by Dextran
Colloid Iron Cocktail, according to manufacturer’s instructions (Stem Cell
Tech., Vancouver, Canada). The treated cells were washed, resuspended
in 5% FBS–Hank’s balanced salt solution, and then applied to a MidiMACS
Separation Column against a magnet (Miltenyi Biotec, Auburn, CA). The
purity of monocytes was defined by flow cytometry (.90%). The mono-
cytes were resuspended in 10% FBS-RPMI and kept on ice until use.
Cytokine production and neutralization: engagement of Fn or anti-
b1 integrin b-subunit with monocytes Six-well tissue culture plates
were coated with human cFn (Upstate Biotech., Lake Placid, NY) or pFn
(Becton Dickinson, Bedford, MA) in phosphate-buffered saline, at varying
concentrations as indicated, and incubated at 4°C overnight. The plates
were washed with phosphate-buffered saline and blocked with 0.05%
heated (65°C for 1 h) bovine serum albumin (Sigma) for 1 h at 37°C, and
washed again. The monocytes were added at 1.5–23106 per ml; after
1 h incubation at 37°C, TNF-α (R&D Systems, Minneapolis, MN) or
Staphylococcus aureus cells (Calbiochem-Novabiochem, La Jolla, CA) were
added in some experiments. For engagement of the β-subunit receptor of
β1 integrin on monocytes via antibodies, two clones of MoAb to CD29
(Lia1/2 and K20, Coulter, Westbrook, ME) were used. Prior to plating
monocytes, Lia1/2 (25 µg per ml) and K20 (1, 10, 25 µg per ml) were
incubated with the cells (2 3 106 per ml) on ice for 45 min and then the
monocytes were plated and blocked with bovine serum albumin (no cFn
present). The supernatants were harvested after 18–22 h incubation at 37°C
in a humidified incubator with 5% CO2. Lipopolysaccharide (Escherichia coli,
0111:B4, Sigma) was used as a positive control.
Neutralization of TNF-a MoAb antihuman TNF-α (M-301, Endogen,
Boston, MA) was used to neutralize TNF-α endogenously produced by
monocytes binding to cFn. Before plating monocytes, MoAb anti-human
TNF-α (10 µg per ml) was mixed with monocytes and then plated into
wells coated with cFn. Cells then were incubated and the supernatants
were harvested after incubation.
Cytokine assay by enzyme-linked immunosorbent assay (ELISA)
After 20 h incubation, supernatants were harvested from incubated mono-
cytes and IL-10, IL-12 p70, and TNF-α protein were determined by
ELISA. The pairs of MoAb to human IL-10 (purified, 18551D; biotinylated,
18562D, PharMingen, San Diego, CA), human IL-12 p70 (purified,
M-122; biotinylated, M-121-B, Endogen), and human TNF-α (purified,
18631D; biotinylated, 18642D, PharMingen) were used as capture (100 ng
per 100 µl per well) and detection antibodies (100 ng per 100 µl per well),
respectively. After first coating capture antibodies, 96-well plates were
incubated at 4°C overnight. The plates were washed and blocked with 3%
bovine serum albumin–phosphate-buffered saline. Recombinant human
IL-10 (PharMingen), IL-12 (R&D Systems), and TNF-α were used as
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Figure 1. Upregulation of EDAF cFn
in the dermis after UV exposure.
Fluorescence immunostaining of skin
biopsies of non-UV-irradiated control (0 h)
and 72 h after UV exposure. fluorescein
isothiocyanate-immunostaining with anti-
cFn MoAb (clone DH1) shows that EDA1
cFn is mainly deposited at the dermal–
epidermal junction in control skin (b, 0 h,
arrow; a, isotype control, scale bar, 50 µm);
in contrast, cFn was apparently upregulated
and is seen as patches and thick fibrillar
deposits (c, isotype control, d, 72 h, short
arrows) at 72 h after UV exposure. The
broken lines separate dermis and epidermis.
n 5 3.
Figure 2. Upregulation of EDAF cFn
in the dermis and association with
induced CD11bF monocytic/
macrophagic cells after UV exposure.
Double staining was performed with
fluorescein isothiocyanate (cFn) and
Rhodamine Red-X (CD11b1 cells). A
few CD11b1 cells are seen in the control
dermis with scattered cFn deposits (a, 0 h,
scale bar, 50 µm). In contrast, at 24 h (b)
and 72 h (c) after UV exposure, evident
monocytic/macrophagic cells (b, c,
arrowhead) infiltrate into dermis and
towards or throughout the epidermis;
aggregates and coarse dot deposits of cFn
are surrounded or in apposition with
CD11b1 cells (b, c, long arrows). n 5 3.
standards, respectively, and samples were simultaneously incubated at room
temperature for 2 h. After washes, detection antibodies were added, and
the plates were washed again. Peroxidase-labeled streptavidin (Kirkegaard
& Perry Lab. Inc., Gaithersburg, MD) 1:1000 was used to develop
o-phenylenediamine dihydrochloride (0.02%) (Sigma) with added hydrogen
peroxide (30%, 1:2000). Fifty percent H2SO4 was used to stop the reaction,
and the plates were read at 492 nm.
Statistical analysis Statistical significance of differences was determined
by Student’s t-test where indicated.
RESULTS
Increased EDAF cFn in human dermis and dermal–epi-
dermal junction after in vivo UV exposure: colocalization
with CD11bF monocytic/macrophagic cells In order to
correlate UV-induced alterations with temporal and spatial changes
in immune cells such as monocytic/macrophagic cells trafficking
to the dermis and epidermis and with cFn production, anti-cFn
(specific for the EDA splice variant) MoAb was used alone (Fig 1,
fluorescein isothiocyanate-labeled) and with anti-CD11b MoAb
(Fig 2, rhodamine-labeled) for double fluorescence immunostaining
on tissue sections.
In unirradiated control skin, cFn deposits faintly and discon-
tinuously in the dermis under the dermal–epidermal junction
(Fig 1a, isotype versus b, 0 h, short arrow). By 72 h, cFn is prominently
upregulated with continuous staining in the dermal–epidermal junc-
tion. Large dermal patches, and dense and thick fibrillar deposits are
also seen in the papillary dermis and perivasculature (Fig 1c, isotype
control versus d, 72 h, short arrows, photographed with matched time
of exposure as Fig 1a–c). This increase was observed in three of three
skin biopsy specimens from three individuals. Biopsies at 24 h and
48h revealedgradually increasingdiffuse deposition (datanot shown),
with maximal staining at 72 h.
In control unirradiated skin with double staining, only a few
CD11b1 large cells (red) are present in papillary dermis and
perivasculature (Fig 2a), which have previously been demonstrated
to represent monocytic/macrophagic cells (Meunier et al, 1995;
Yoshida et al, 1998); in addition, cFn is visualized (as in Fig 1b) as
modest papillary dermal staining and perivascular staining. By 24 h
after UV, CD11b1 cells (Figs 2b, 24 h, arrowhead) are clearly
increased in numbers and intensity and appear not only in the
dermis but also at the dermal–epidermal junction and in the
epidermis. Concomitantly, cFn is increased in intensity throughout
the papillary dermis. Moreover, the fine deposits of cFn become
aggregates and coarse dots, as well as fibrils. Interestingly, some
larger aggregates are in apposition to or appear to be surrounded
by CD11b1 monocytic/macrophagic cells (Figs 2b, 24 h, long
arrows). By 72 h, dermal infiltration by CD11b1 monocytic/
macrophagic cells is prominent (Fig 2c, arrowhead) and the upper
epidermis is disrupted and edematous. CD11b1 cells are also present
in the epidermis. The interaction of monocytic/macrophagic cells
with aggregates and dots of cFn in the dermis (Figs 2c, 72 h, long
arrows) is localized to the dermis and the dermal–epidermal junction.
EDAF cFn mRNA is upregulated after UV exposure To
determine whether EDA1 Fn is produced as a result of local
cellular synthesis, we assayed for the EDA splice variant of cFn
by reverse transcriptase–PCR using EDA-specific oligonucleotide
primers (see Materials and Methods). In agreement with the immuno-
staining findings, EDA1 mRNA was upregulated in the dermis
after UV exposure at 72 h relative to anatomically matched
unirradiated skin from the same volunteer, with β-actin as controls
(n 5 2) (Fig 3). EDA1 mRNA was also detected in UV-exposed
epidermis, but to a much lesser extent (data not shown). Thus,
both immunostaining and reverse transcriptase–PCR provide evid-
ence that EDA1 cFn is induced locally post-UV exposure.
IL-10, but not IL-12, is markedly upregulated by monocyte
binding to cFn After UV injury, we hypothesized that circulating
leukocytes, such as monocytes trafficking from activated blood
vessels into the dermis and epidermis, undergo modulation of
their immunoregulatory cytokines via binding to the encountered
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Figure 3. EDAF Fn mRNA expression is upregulated in skin 72 h
post-UV (four minimal erythemal doses) exposure. Dermis was
separated from epidermis by dispase, and ground with liquid nitrogen.
Total RNA was prepared and subjected to reverse transcriptase–PCR.
β-actin was used as a control gene (lower panel). The relative density of
PCR products was quantitated as shown (bars in the upper graph) after
normalization to that of β-actin. Arrow indicates EDA1 band of PCR
product. C, non-UV irradiated control skin. 72 h, post-UV (four minimal
erythemal doses) irradiated skin. n 5 2.
Figure 4. IL-10 and TNF-a protein, but not IL-12 p70 production,
are enhanced in a concentration-dependent manner by monocyte
binding to cFn. Cytokines were measured by ELISA from supernatants
harvested after 20 h incubation of purified monocytes (1.5–2 3 106 per
ml) on cFn-coated plates. *p 5 0.045 and **p 5 0.001 relative to cFn
0 µg per ml, respectively. Error bars, SEM. n 5 6.
extracellular matrix molecules, particularly when the EDA1 splice
variant is abundant, because of its enhanced ability to bind via β1
integrins. In order to clarify the effects of increased exposure to
dermal cFn on immigrating monocytes, different concentrations of
cFn (1, 5, 20 µg per ml) and pFn (20 µg per ml) were employed
in in vitro studies. IL-10 was dramatically induced by purified
monocytes binding to cFn in a concentration-dependent manner
(Fig 4, hatched), but not by pFn (data not shown). IL-12 p70 was
not detectable. TNF-α production was also enhanced by monocytes
binding to cFn by ELISA (Fig 4), but not by pFn (data not shown);
however, the magnitude of induction was less robust than that of
IL-10. IL-1β induction was similar to TNF-α (data not shown).
The baseline of monocyte production of TNF-α and IL-10
Table I. The production of IL-12 p70 protein by monocyte
binding to cellular fibronectin and stimulation with SAC
cFN (µg per ml) IL-12 p70 (pg per ml)a
no SACb 1SAC
0 ,10 351 6 164
20 40 6 39 344 6 75c
aResults are expressed as the mean 6 SEM (n 5 3).
bSAC concentration, 0.001%.
cp.0.05 relative to monocytes with no cFn binding.
were not detectable (,10 pg per ml) implying that monocytes
postpurification were in a resting state.
Because IL-12 production by monocytes can be downregulated
by complement receptor 3 (Marth and Kelsall, 1997; Sutterwala
et al, 1997; Yoshida et al, 1998), we asked if β1 integrin signaling
via Fn can also be involved in the regulation of IL-12. Monocytes
were stimulated with Staphylococcus aureus cells (a potent stimulator
for IL-12 production by monocytes) after placement on dishes
coated with/without cFn. cFn had no effect on IL-12 production
(Table I), however, indicating that, although cFn may play a part
in inducing the IL-10high phenotype of UV-induced monocytic/
macrophagic cells in vivo, the inhibition of IL-12 production of
in vivo cells cannot be attributed to β1 ligation/signaling. It is
clear, however, that cFn can induce IL-10 without concomitantly
inducing IL-12.
b1 integrin b-subunit (CD29) alone can strongly induce
TNF-a and IL-10 production by blood monocytes The
principal Fn receptors expressed by blood monocytes are integrins
α5β1 and α4β1 (Hemler, 1990). Therefore, if Fn is acting through
β1 signaling, antibodies to the β1 β-subunit (CD29), common to
β1 integrins, should also affect TNF-α and IL-10 production by
monocytes. Two different MoAb clones of CD29 (Lia1/2 and
K20) were used. Both TNF-α (2596 6 192 and 1854 6 451 pg
per ml) and IL-10 (2906 6 365 and 3080 6 682 pg per ml)
protein were dramatically induced (n 5 2) with Lia1/2 and
K20 [which was concentration-dependent (data not shown)] by
monocytes, respectively, in culture without cFn coated substrate
(Fig 5). The baseline of the isotype mouse IgG2a (K20) was
undetectable (,10 pg per ml) and IgG1 (Lia 1/2) was 39 6 39
for TNF-α and 246 6 246 pg per ml for IL-10, respectively.
TNF-α and IL-10 production by lipopolysaccharide-stimulated
monocytes as positive controls were 3491 6 111 and
3881 6 1045 pg per ml, respectively. The marked induction of
TNF-α by β1 cross-linking using antibodies is more than 10-fold
greater than the TNF-α response to cFn, indicating somewhat
differing signaling responses for TNF-α; by contrast, the IL-10
response was quite similar. Neither antibodies nor isotype controls
could stimulate significant amounts of IL-12 (data not shown),
suggesting distinct signaling patterns through β1 integrin, and
confirming the lack of endotoxin in the antibodies.
Induction of IL-10 production in monocytes by cFn is partly
mediated by endogenous TNF-a Because TNF-α plays an
important part in human monocyte IL-10 synthesis (Wanidworanun
and Strober, 1993) and because cFn can also induce TNF-α
production by monocytes, we asked whether induced endogenous
TNF-α or exogenous TNF-α is important for the induction of
IL-10 production by monocytes. First, recombinant human TNF-α
was added after monocytes were plated on different concentrations
of cFn (5, 20 µg per ml) coated wells. TNF-α exerted a consistent
enhancement of IL-10 production by monocytes at each tested
concentration of cFn (Table II); however, the magnitude of the
effect was modest as compared with Fn of β1 signaling.
Despite modest effects during exogenous administration in the
presence of cFn, TNF-α appears to be an important endogenous
enhancing mediator of IL-10 in this system (Fig 6). For neutraliz-
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Figure 5. TNF-a and IL-10 production by monocytes is strongly
stimulated by the b chain of b1 integrins (CD29). Two clones of
MoAb, Lia1/2 (IgG1) and K20 (IgG2a), were used. The MoAb or isotype
control antibodies (IgG1, IgG2a) were first incubated with monocytes,
respectively, on ice for 45 min and then the monocytes were plated on
bovine serum albumin coated wells. Cytokines were measured by ELISA
from supernatants harvested after incubation of monocytes for 20 h. C,
controls. Lipopolysaccharide-stimulated monocytes are shown for
comparison. (a) and (b) show TNF-α and IL-10 production, respectively.
Error bars, SEM. n 5 2.
ation of TNF-α, monocyte activation by Fn was performed by
adding MoAb anti-TNF-α to the cultures prior to and continuously
during monocyte binding to cFn. IL-10 production was significantly
reduced after induced endogenous TNF-α was neutralized;
1519 6 115 pg per ml IL-10 in cultures with cFn plus isotype
versus 694 6 66 pg per ml in cultures with MoAb anti-human
TNF-α (n 5 4, p 5 0.0008, Fig 6). The mean inhibition
was 54%, implying that cFn-induced endogenous TNF-α is an
important, but not the sole, mediator of IL-10 induction by cFn
in monocytes.
DISCUSSION
Previous studies of the skin microenvironment after UV irradiation
in both mice and humans showed that inflammatory leukocytes
migrate into the dermis and epidermis (Cooper et al, 1986, 1993;
Meunier et al, 1995), with preferential infiltration of monocytes
characterized by IL-10high and IL-12low phenotype (Kang et al, 1994,
1998). This study demonstrates one of the possible mechanisms of
this induced monocyte phenotype.
Monocyte/macrophagic cells are rich in receptors for immuno-
globulins, complement, and extracellular matrix components such
Figure 6. IL-10 production by monocytes binding to cFn is
markedly reduced after neutralization of TNF-a. Anti-human TNF-α
(10 µg per ml) or IgG1 isotype (1 iso) was added to purified monocytes
prior to incubation on cFn-coated (20 µg per ml) plates. IL-10 was
measured by ELISA from supernatants harvested after 20 h incubation. C,
control. *p 5 0.0008 relative to iso. Error bars, SEM. n 5 4.
Table II. Minimal additional effect of exogenous TNFa on
cellular fibronectin-stimulated IL-10 production
cFn (µg per ml) IL-10 (pg per ml)a
No TNFα 1TNFα p valueb
0 ,10 60 6 38
5 621 6 249 846 6 249 0.017
20 1622 6 339 1852 6 368 0.025
aResults are expressed as the mean 6 SEM (n 5 6).
bPaired t-test (n 5 6).
as Fn. Fn is one of the most important ligands for β1 integrin that
is apparently expressed on the surface of blood monocytes such as
α5β1 and α4β1. After UV injury, Fn deposition in skin can be
enhanced by leakage of pFn from blood vessels, or can be a novel
synthetic product from the cells in the skin. Upon influx of blood
monocytes into the skin, monocyte/macrophage cell binding to
Fn can take place. Therefore, we have sought to link Fn upregulation
with monocytic/macrophagic cells function in skin post-UV
irradiation.
After UV exposure, immunofluorescence staining of human skin
with MoAb to cFn (clone DH1), which is specific to the extra
domain (EDA sequence) of cFn, shows that EDA1 cFn is upregul-
ated at 72 h with large patches and dense, abundant thick fibrillar
deposits (Fig 1d, short arrows). In order to query the upregulation
of EDA1 cFn at the mRNA level, the primers for the EDA splice
variant of cFn were used for reverse transcriptase–PCR. EDA1
bands are present in the dermis of UV-exposed skin, but not
control skin (Fig 3). EDA1 Fn is an isoform known to be expressed
in carcinoma (Oyama et al, 1993) as well as in wound healing
(Brown et al, 1993). The upregulation of EDA1 Fn in UV-exposed
skin might be directly caused by an UV carcinogenic effect resulting
in tissue specific alternative splicing or due to wound healing
after UV injury. To date, increased UVA-and UVB-induced Fn
biosynthesis has been reported only in hairless mice (Schwartz,
1988; Boyer et al, 1992). We confirm Fn upregulation in human
skin and further identify the deposited Fn as the functionally
important EDA1 cFn splice variant.
In addition, we examined the spatial relationship of infiltrating
CD11b1 monocytic/macrophagic cells to UV-induced cFn. The
numbers of CD11b1 monocytic/macrophagic cells were clearly
increased at 24 h in the dermis (Fig 2b, red cell, arrowhead) and
near epidermis, and at 72 h, they were found throughout the skin
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(Fig 2c, arrowhead). UV-induced monocytic/macrophagic cells and
cFn were closely associated physically, suggesting that signaling may
well have occurred in vivo via the Fn–monocytic/macrophagic cell
interaction, perhaps resulting in the in vivo phenotype induced in
monocytes as they enter and encounter UV-modified skin. To
address the latter question, we used purified monocytes from
peripheral blood to model the proposed in vivo sequence of resting
monocyte entry and Fn exposure in UV-exposed skin. Because
tissue macrophages have already been stimulated in this altered skin
milieu, they would not model well the resting monocyte as it exits
the blood and encounters the dermal perivasculature and papillary
dermis. That in vivo signals in UV-exposed skin in monocytes can
be modeled in vitro to induce in vivo phenotype has been demon-
strated to be valid in studying ligation to the β2 integrin of blood
monocytes (Yoshida et al, 1998; Hammerberg et al, 1998).
To determine cytokine production by monocyte binding to
Fn, monocytes were incubated with cFn. We found that IL-10
upregulation was cFn concentration-dependent, whereas changes
in IL-12 regulation were not observed. TNF-α was also but
relatively slightly upregulated in parallel with IL-10 production
(Fig 4). In contrast, neither IL-10 nor TNF-α production were
upregulated by monocyte binding to pFn (data not shown). These
data indicate clearly that cFn containing EDA plays an important
part in the upregulation of IL-10 and TNF-α production by
monocytes, suggesting that the close physical association of mono-
cytic/macrophagic cells with cFn in vivo by immunofluorescence
staining of skin is likely an active process, involving alteration of
Fn conformation or change of the spacing between well-established
binding sites.
To examine whether the β chain, which is common to β1
integrins, may be responsible for the induction of IL-10 and TNF-α
by monocyte binding to cFn, two clones of MoAb to CD29 were
used to stimulate cytokine production. Indeed, the β chain of β1
integrin (both Lia1/2 and K20) did consistently and markedly
induce IL-10 and TNF-α production (Fig 5), showing an important
role of β1 integrin signaling. It has been reported that in monocytes,
signaling through the VLA integrins for IL-1 induction requires
only divalent cross-linking, which is consistent with our results,
and does not always need an additional secondary antibody to
cross-link for signaling (Yurochko et al, 1992). It is known that β1
integrin signaling induces tyrosine phosphorylation (Lin et al, 1995)
and induces activation of mitogen-activated protein kinase (Chen
et al, 1994). Using lipopolysaccharide stimulation, mitogen-activated
protein kinase has been shown to play a key role in the induction
of IL-10 and TNF-α by monocytes (Meisel et al, 1996; Foey et al,
1998). We presume that these mechanisms are involved in Fn-
mediated production of IL-10 and TNF-α by monocytes.
In addition to being a responding element, monocytes may also
be a source of cFn in UV-exposed skin. There are several potential
candidates for the cellular source of the enhanced cFn found after
UV, including keratinocytes, fibroblasts, endothelial cells, and
monocytes (Clark, 1983; Brown et al, 1993).
Although CD11b1 cells are present at 24 h after UV, this actually
precedes the time at which the most considerable amounts of cFn
were found, raising the possibility that other factors are involved
in the infiltration of monocytes and their IL-10 production. The
early induction of IL-10, prior to papillary dermal and dermal–
epidermal junction Fn deposition after UV, may be through signals
distinct from Fn. We recently found that complement degradation
products (iC3b) are involved in monocyte induction of IL-10
within 24 h after UV (Yoshida et al, 1998). We hypothesize that
monocytic/macrophagic cell IL-10 is initially stimulated by both
iC3b and perivascular cFn and then is sequentially stimulated by
increasing amounts of cFn in the 72 h period after UV, thus
sustaining the IL-10 production as iC3b wanes.
TNF-α can also be induced and released by keratinocytes and
dermal mast cells after UV irradiation (Kock et al, 1990; Walsh,
1995). To model in vivo conditions further in UV-exposed skin,
recombinant TNF-α was added, and resulted in further enhance-
ment of IL-10 production (Table II), although this was a modest
effect. Thus TNF-α could potentiate IL-10 production; TNF-α
could act either via endogenous (Foey et al, 1998) or exogenous
sources. To clarify that TNF-α induced by monocytes after
binding to cFn strongly participates in the induction of IL-10, the
neutralization of induced endogenous TNF-α was performed.
Our data showed that after neutralization of TNF-α, the IL-10
production was greatly reduced (.50%). Thus, the endogenous
TNF-α here does play an important, perhaps autocrine, role (Foey
et al, 1998) and may desensitize the effect of further exogenous
TNF-α on IL-10 production by monocytes, as shown in this study.
Although it is known that Fn is increased in psoriasis (Fyrand,
1979; Clark, 1983) and that pFn plays an important part in the
regulation of keratinocyte cell cycling in psoriasis (Bata-Csorgo
et al, 1998), a role for cFn after UV therapy for psoriasis has not
been explored. One potential mechanism is that UV can upregulate
cFn in the dermis, and cFn, but not pFn, interacts with UV-
induced monocytic/macrophagic cells after UV exposure of the
skin, resulting in the enhancement of IL-10 production as shown
in this study. It has recently been demonstrated that IL-10 is very
useful for psoriasis treatment (Asadullah et al, 1998).
In summary, the oncofetal isoform EDA of cFn can be induced
in skin post-UV irradiation. IL-10 and TNF-α, but not IL-12, are
significantly upregulated by blood monocytes binding to cFn, but
not pFn. Endogenous/autocrine TNF-α induced by monocytes
binding to cFn plays an important part in the upregulation of
IL-10. Thus, β1 integrin binding provides signals to monocytes for
generating the IL-10high monocytic/macrophagic cell phenotype
in the micromilieu of the skin after UV injury.
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